Who is sponsoring NCT07361146?

NCT07361146 is sponsored by Mohammad Arian.

What drugs are being tested in NCT07361146?

Interventions in NCT07361146: Physical Therapy Exercise Program.

What condition does NCT07361146 study?

NCT07361146 studies End-stage Renal Disease (ESRD), Chronic Kidney Disease, Hemodialysis Patients, Physical Rehabilitation During Dialysis.

Is NCT07361146 still recruiting?

NCT07361146 is currently recruiting now. Last updated 22 January 2026.

Last reviewed 2026-01-22 · How we verify

NCT07361146: DIAL-PT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Comparative Study of Intradialytic vs. Pre-Dialysis Physical Therapy Interventions in Individuals Undergoing Hemodialysis: A Randomized Controlled Trial

Recruiting now NA Last updated 22 January 2026

What this trial tests

NA trial testing Physical Therapy Exercise Program in End-stage Renal Disease (ESRD) in 72 participants. Currently enrolling.

Timeline

2 March 2025

Primary endpoint
2 March 2027

2 June 2027

Quick facts

Lead sponsor	Mohammad Arian
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	72
Start date	2 March 2025
Primary completion	2 March 2027
Estimated completion	2 June 2027
Sites	1 location across Kuwait

Drugs / interventions tested

Physical Therapy Exercise Program

Conditions studied

End-stage Renal Disease (ESRD) — all drugs for End-stage Renal Disease (ESRD) →
Chronic Kidney Disease — all drugs for Chronic Kidney Disease →
Hemodialysis Patients — all drugs for Hemodialysis Patients →
Physical Rehabilitation During Dialysis — all drugs for Physical Rehabilitation During Dialysis →

Sponsor

Mohammad Arian

Who can join

Adults 21 to 65, any sex, with End-stage Renal Disease (ESRD) or Chronic Kidney Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial aims to compare the effectiveness of two different timings of physical therapy for individuals undergoing hemodialysis: intradialytic (during dialysis) and pre-dialysis (before dialysis). The study seeks to determine which approach provides better improvements in physical function, quality of life, and biochemical outcomes such as hemoglobin and electrolyte levels. A total of 72 adult participants with end-stage renal disease (ESRD) receiving hemodialysis will be randomly assigned to one of two groups. Both groups will receive standardized educational sessions on the benefits and safety of exercise before beginning the intervention. Participants in the intradialytic group will perform supervised exercises during their dialysis sessions, while those in the pre-dialysis group will complete similar exercises before their dialysis sessions. Each participant will undergo the intervention twice per week for 12 weeks. Primary outcomes include physical function, assessed using the Six-Minute Walk Test and the Five Times Sit-to-Stand Test. Secondary outcomes include hemoglobin levels, electrolyte balance, and health-related quality of life measured by the KDQOL questionnaire. The study will be conducted at Mubarak Al-Abdullah Al-Jaber Al-Sabah Dialysis Center, Kuwait, following ethical approval from the Ministry of Health Research Ethics Committee. The results are expected to inform best practices for integrating physical therapy into dialysis care to enhance the health, safety, and well-being of individuals undergoing hemodialysis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for End-stage Renal Disease (ESRD)

Currently open trials in the same condition.

NCT06868888 — Rheological Functions of Erythrocyte in ESRD · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07361146 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mohammad Arian
Last refreshed: 22 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07361146.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing